It was further demonstrated that 3,5-bisbromoemodin notably reduced cancer stemness in the 3D spheroid assay, and showed a comparable anti-proliferative activity against A549 cell to shRNA-mediated ATP citrate lyase knockdown, therefore making it an encouraging prodrug for tumor therapy [204]. Here, ACLY is linked to cancer.